Plasma cholesterol and related lipid levels of seemingly healthy public service employees in Kampala, Uganda

African Health Sciences

Volumn 6, Issue 3, 2006, Pages 139-144

  Bimenya, G S ^a   Okot, J K ^b   Nangosa, H ^b   Anguma, S A ^b   Byarugaba, W ^a  

^a MAKERERE UNIVERSITY   (Uganda)

^b MULAGO HOSPITAL   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADMINISTRATIVE PERSONNEL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIET RESTRICTION; DYSLIPIDEMIA; FEMALE; GOVERNMENT; HEALTH EDUCATION; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; UGANDA; URBAN POPULATION;

BLOOD GLUCOSE; CHOLESTEROL; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LIPIDS; MALE; PUBLIC HEALTH ADMINISTRATION; UGANDA;

EID: 34347388682     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Brown WV. Cholesterol absorption inhibitors: defining options in lipid management Clin. Cardiol. 2003;26:259-264.
2. Wierzbick AS, Mikhailids D P, Warp R, Schachter M, Simpson WG and Byrne CB. Statin-fibrate combination therapy for hyperlipidemia a review. 2003;19(3):155-168.
3. Schwandt P. The importance of reaching lipid targets: Statins and prevention of atherosclerosis Int J. Clin. Pract. 2003; 57(4):396-404.
4. Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K. Prevention of coronary heart disease in clinical practice: recommendations of second joint task force of European and other societies on coronary prevention Atherosclerosis 1998:199-270.
5. WHO Technical Report 727, 1985. Report of a WHO study group on diabetes mellitus.
6. National cholesterol education programe expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III) JAMA 2001:285:2486-97.
7. Harvey S. Cholesterol and other lipids. http://www.wellconnected.com/ report.cgi/000023-7.htm reviewed 5/8/2005.
8. Brizzi P, Tonlo G, Carussilo F, Malaguarnera M, Maioli M, Musumeci S. Plasma lipid composition and LDL oxidation. Clin. Chem. and Lab Med 2003;41(1):56-60.
9. Fossati P. and Princip'e L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem. 1982;28:2077-2088.
10. Schettler G. Niissel E. Pravantimed. Massanahmen zur pravention der Arteriosklerosc. Albeitsmed. Sozialmed. 1975, 10:25.
11. Sugiuchi H, Ugi Y, Okabe H, Irie T, Uekama K, Kayahara N and Miyauchi K. Direct measurement of -High Density lipoprotein cholesterol in serum with polyethylene glycol modified enzymes and sulfated x-cyclodextrin. Clin. Chem. 1995;41:717-2723.
12. Rifai N, Waruick GR, McNamara JR, Belcher JD, Grinstead GF and Frantz I.D. JR. Measurement of Low density lipoprotein cholesterol in serum a status report. Clin. Chem. 1992;38:150-160.
13. Sachiko I, Okada M, Matsui H, Honita Y. A new direct method for measuring HDL-cholesterol which does not produce any biased values.
14. Borner K, and Klose S. Enzymatic determination of total cholesterol with the Greiner Selective analyser (GSA-II). J. V clin. Chem. Clin Biochem 1977;15(3):121-30
15. Jones RG and Payne RB. Clinical investigations and statistics in laboratory medicine. Statistics questions and kinds of data, Chapter 1 Page 1-25. ACBVenture publications 1997. Association of Clinical Biochemistry. 2 Carlton House Terrace, London SWIY 5AF.
16. Genest JJ, McNamara JR, Salem DN, Schaefer EJ. Prevalence of risk factors in men with premature coronary artery disease. M J Cardiol, 1991;67:1185-1189.
17. Grundy SM, Cleeman J, Merz CN, Brewer HB Jr et al., Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 2004;110(2):227-239.
18. Castelli WP, Garrison RJ,Wilson PW, Abbott RD, Kallousdian S.,Kennel W.B. Incidence of Coronary heart disease and lipoprotein levels: The Fremingham Study JAMA 1986;256:2835-2838.
19. Gordon T,Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease The Fremingham Study Am. J. Med. 1977;62:707-714.
20. Kinosian B,Glick H,Garland G, Cholesterol and coronary heart disease: predictive risks by levels and ratios. Ann. Intern. Med. 1994;121:641-647.
21. Criqui MH and Golomb BA. Epidemilogical aspects of lipid abnormalities. Am. J. Med. 1998;105(1A0:485-575.
22. Loock ME and vanStadem DA. Ischaemic heart disease in urban blacks. S. Afr. Med. J. 1983;63:635.
23. Johnson R, McNuth P, MacMahon S and Robson R. Use of the Friedwalf formula to estimate LD.L. Cholesterol in patients with chronic renal failure on dialysis. Chin. Chem. Nor. 1st 997 43 (11):2183-2184.
24. Njelekera M, Negishi H, Nara Y, et al., Cardiovascular risk factors in Tanzania: A revisit. Acta Trop. 2001;79:231-239.
25. Kamotho C, Ogola EO, Joshi M, Gikonyo D. Cardiovascular risk factor profile of black Africans undergoing coronary angiography. E. Afr. Med. J. 2004;81:82
26. Pekka Purka. Health-related life style is the key. Bull. World Health Organization 2001;79:985-986.
27. Beaglehole R, Saracci R, Ponico S, Cardiovascular diseases: causes, sueveillance and prevention. Intern. J. Epodemiol. 2001;30:51-54